K. Sewerin

Validation of peptide mapping for protein identity and genetic stability. Biologics and biotechnology section, pharmaceutical research and manufacturers of America.

M. Federici, M. Costello, J. Tuls, 1996, Biologicals : journal of the International Association of Biological Standardization.

Localization of a factor VIII binding domain on a 34 kilodalton fragment of the N-terminal portion of von Willebrand factor.

D. Meyer, J. Girma, M. Kalafatis, 1987, Blood.

Binding of native and thrombin activated factor VIII to platelets.

L. Andersson, K. Sewerin, 1983, Thrombosis research.

LOCALIZATION OF A FACTOR VIII BINDING DOMAIN ON THE N-TERMINAL PORTION (FRAGMENT SpIII) OF VON WILLEBRAND FACTOR

D. Meyer, J. Girma, M. Kalafatis, 1987, Thrombosis and Haemostasis.

Isolation and characterization of human factor VIII: molecular forms in commercial factor VIII concentrate, cryoprecipitate, and plasma.

K. Huang, J. Smart, H. Sandberg, 1986, Proceedings of the National Academy of Sciences of the United States of America.

Factor VIII Procoagulant Protein Interacts with Phospholipid Vesicles Via its 80 kDa Light Chain

S. J. Edwards, T. Barrowcliffe, G. Kemball-Cook, 1988, Thrombosis and Haemostasis.

Rapid analytical tryptic mapping of a recombinant chimeric monoclonal antibody and method validation challenges.

M. Mulkerrin, K. Kannan, R. Harris, 1997, Journal of pharmaceutical and biomedical analysis.